참고문헌
- van Nood E, Vrieze A, Nieuwdorp M, et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 2013;368:407-415.
- Paramsothy S, Kamm MA, Kaakoush NO, et al. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial. Lancet 2017;389:1218-1228.
- U.S. Food and Drug Administration. Enforcement policy regarding investigational new drug requirements for use of fecal microbiota for transplantation to treat Clostridium difficile infection not responsive to standard therapies [Internet]. Silver Spring (MD): U.S. Food and Drug Administration, c2022 [cited 2024 Aug 8]. Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/enforcement-policy-regarding-investigational-new-drug-requirements-use-fecal-microbiota.
- Peery AF, Kelly CR, Kao D, et al. AGA clinical practice guideline on fecal microbiota-based therapies for select gastrointestinal diseases. Gastroenterology 2024;166:409-434.
- Lamb CA, Kennedy NA, Raine T, et al. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut 2019;68(Suppl 3):s1-s106.
- Lopetuso LR, Deleu S, Godny L, et al. The first International Rome Consensus Conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease. Gut 2023;72:1642-1650.
- Park J, Hong SN, Lee HS, et al. Perception of fecal microbiota transplantation in patients with ulcerative colitis in Korea: a KASID multicenter study. Korean J Intern Med 2024;39:783-792.
- Liu Y, Alnababtah K, Cook S, Yu Y. Healthcare providers' perception of faecal microbiota transplantation with clostridium difficile infection and inflammatory bowel disease: a quantitative systematic review. Therap Adv Gastroenterol 2021;14:17562848211042679.
- Gweon TG, Lee YJ, Yim SK, et al. Recognition and attitudes of Korean physicians toward fecal microbiota transplantation: a survey study. Korean J Intern Med 2023;38:48-55.
- Zeitz J, Bissig M, Barthel C, et al. Patients' views on fecal microbiota transplantation: an acceptable therapeutic option in inflammatory bowel disease? Eur J Gastroenterol Hepatol 2017;29:322-330.